UTI Mid Cap Fund: Healthy long-term track record

While the fund has underperformed in recent years, amid a largely growth and momentum-driven rally, its longer term track record is healthy.

BCCL
With a 10-year return of 16.5%, the fund has comfortably outperformed both the category average (13.9%) and the benchmark index (12.1%).
ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.

UTI Mid Cap Fund

How has the fund performed?
With a 10-year return of 16.5%, the fund has comfortably outperformed both the category average (13.9%) and the benchmark index (12.1%).


The fund has comfortably beaten both the index and the category average over the past decade.

Untitled-3
As on 22 Jan 2018

Annualised performance (%)
The fund has underperformed across 1-, 3- and 5-year periods.
Untitled-4
As on 22 Jan 2018

Yearly performance (%)
The fund has struggled to outperform in recent years.
Untitled-12

BASIC FACTS
Date of launch :7 Apr 2004
Category : Equity
Type : Mid cap
Average AUM : Rs 4,441 cr
Benchmark : Nifty Free Float and Midcap 100 Index
ADVERTISEMENT

WHAT IT COSTS
NAVS*
Growth option : Rs 118
Dividend option : Rs 64
ADVERTISEMENT
Minimum investment : Rs 5,000
Minimum SIP amount : Rs 500
Expense ratio (%)^ : 2.27
Exit load: 1% for redemption within 365 days

*As on 22 Jan 2018

Fund manager : Lalit Gopalan Nambiar
Tenure: 1 year and 9 months
Education: B. COM (H), MMS AND CFA

Where does the fund invest?
The fund portfolio is more compact now, allowing healthy exposure in top bets.
Untitled-6

How risky is it?
The fund's risk-return profile has taken a hit in the past few years.
Untitled-7

Wherever not specified, data as on 31 Dec 2017. Source: Value Research

Should you buy?
This is a true-to-label mid-cap fund with a focus on turnaround stories. It identifies businesses witnessing weaker earnings growth in relation to their true potential. The aim is to spot stocks with favourable risk reward profiles and to ride their earnings recovery.

With a bottom-up process, the fund is quite agnostic to value and growth, even as it retains some value stocks because of their growth potential. Under the current manager, the portfolio has been pruned from 100-plus to around 65 stocks, allowing for meaningful positions in high conviction bets. While the fund has underperformed in recent years, amid a largely growth and momentum-driven rally, it's longer term track record is healthy.

Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

Top Mutual Funds

3 M(%)
6 M(%)
1 YR(%)
3 YRS(%)

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Save with Tax planning SIP's

More from our Partners

Business News › Wealth › Invest › UTI Mid Cap Fund: Healthy long-term track record
Text Size:AAA
Success
This article has been saved

*

+